4 files

Totality of Evidence Supporting the Use of ABP 980, a Trastuzumab Biosimilar: Practical Considerations

posted on 24.12.2020, 09:24 by Hans-Christian Kolberg, Georgia Savva Demetriou, Vladimir Hanes

Article full text

The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The pre-typeset version is available above.

The above summary slide and videos represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.